News & Views

Miele and Steelco Join Forces

Jul 11 2017 Read 801 Times

The family-owned Miele and Steelco Groups have agreed to join forces by combining their skills in medical technology. One result is that Miele is to acquire a controlling stake in the Steelco Group, whilst Steelco founders remain at the helm of the group. Thanks to this combination, the medical technology division within the Miele Group is set to grow by around one third to approximately €250 million per annum. The overarching aim is to provide clients with an even broader and more sophisticated range of products as well as the best possible service, both before and after the sale. This transaction is still subject to approval of the antitrust authorities.

Miele counts among the world’s most reputable manufacturers of cleaning, disinfection and sterilisation products for medical and laboratory applications. This includes the project business covering the planning and furnishing of central sterile supply departments (CSSD) in hospitals. “Together with Steelco, Miele can combine its claim to quality and innovation leadership with a significantly broader product portfolio, and hence expand its market position,” said Andreas Barduna, Commercial Director of Miele Professional business.

Steelco, producer of CDS equipment mainly for the hospital and pharma sectors with an excellent reputation in the market. The founder and CEO Ottorino Casonato is to remain responsible for the management of Steelco, assisted by the co-founders Fabio Zardini and Ivone Capovilla as well as by his daughter Nicoletta Casonato. Miele, on the other hand, has a majority representation on the supervisory board of the Steelco Group. “For us, Miele is a strong and dependable partner for a joint and successful future and represents an excellent match,” said Ottorino Casonato.

Miele has its own sales and service structures providing effective coverage in its core markets, whereas Steelco will be contributing its strong dealer network in over 100 countries. A further central Miele asset is represented by the numerous patented USPs on current models and on model generations under development in the medical field. The Steelco Group, for its part, brings with it an even broader and highly distinguished product portfolio in the area of disinfection and sterilisation. Furthermore, Steelco is highly successful in the specialised segment relating to the reprocessing of componentry used in pharmaceutical production – an area new to Miele.

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Digital Edition

Lab Asia March / April 2018

April 2018

In this issue... Chromatography - Biphenylpropyl Modified Silica - New Application Book Offers Expertise in GPC Analysis - Same Separation, Speedier Solution - Advanced Laboratory Manageme...

View all digital editions



Apr 21 2018 Beijing, China

Making Pharmaceuticals UK

Apr 24 2018 Ricoh Arena, Coventry, UK

Analytika Expo 2018

Apr 24 2018 Moscow, Russia

Chemspec India 2018

Apr 25 2018 Mumbai, India

Analytica Anacon India & IndiaLabExpo

Apr 25 2018 Mumbai, India

View all events